[Effect of various drugs in vivo and in vitro on the results of the most frequently performed enzymatic determinations in a clinical laboratory].
D000410:Alanine Transaminase / Q000037:antagonists & inhibitors; D000469:Alkaline Phosphatase / Q000097:blood; D000632:Aminopyrine / Q000494:pharmacology; D000681:Amylases / Q000378:metabolism; D000983:Antipyrine / Q000494:pharmacology; D001205:Ascorbic Acid / Q000494:pharmacology; D001219:Aspartate Aminotransferases / Q000097:blood; D002747:Chlorpropamide / Q000494:pharmacology; D004796:Clinical Enzyme Tests; D003975:Diazepam / Q000494:pharmacology; D004338:Drug Combinations / Q000494:pharmacology; D004789:Enzyme Activation / Q000187:drug effects*; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D004917:Erythromycin / Q000494:pharmacology; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D007770:L-Lactate Dehydrogenase / Q000037:antagonists & inhibitors; D008297:Male; D010389:Pemoline / Q000494:pharmacology; D010653:Phenylbutazone / Q000494:pharmacology; D011044:Poland; D012459:Salicylates / Q000494:pharmacology
D004338:Drug Combinations; D004791:Enzyme Inhibitors; D012459:Salicylates; D000632:Aminopyrine; D004917:Erythromycin; D010389:Pemoline; C003769:phenylbutazone, propyphenazone drug combination; D007770:L-Lactate Dehydrogenase; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D000469:Alkaline Phosphatase; D000681:Amylases; D010653:Phenylbutazone; D001205:Ascorbic Acid; D003975:Diazepam; D000983:Antipyrine; D002747:Chlorpropamide
Wpływ niektórych leków in vivo i in vitro na wyniki najcześciej wykonywanych oznaczeń enzymatycznych w laboratorium klinicznym.